Current ratio decreased 56.7%
Current ratio changed -56.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
0.25→0.114 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CELU financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Working capital / assets moved 1221 bp lower
Working capital / assets changed -1221 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
-43.20%→-55.41%4 prior comparisons
Current liabilities decreased 13.7%
Current liabilities changed -13.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$69.2M→$59.7M4 prior comparisons
Operating cash-flow margin moved 298 bp lower
Operating cash-flow margin changed -298 basis points from the comparable as-filed period.
-17.42%→-20.40%3 prior comparisons
Operating cash flow decreased 10.9%
Operating cash flow changed -10.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
-$999,000→-$1.1M4 prior comparisons
R&D / revenue moved 2110 bp lower
R&D / revenue changed -2110 basis points from the comparable as-filed period.
58.44%→37.33%3 prior comparisons
Revenue decreased 5.3%
Revenue changed -5.3% from the comparable as-filed period.
$5.7M→$5.4M3 prior comparisons
Working capital decreased 2.6%
Working capital changed -2.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
-$52.0M→-$53.3M4 prior comparisons
Cash & equivalents increased 25.6%
Cash & equivalents changed +25.6% from the comparable as-filed period.
$293,000→$368,0003 prior comparisons
Total assets decreased 22.8%
Total assets changed -22.8% from the comparable as-filed period.
$128.9M→$99.5M3 prior comparisons
Operating cash flow changed across a sign change
Operating cash flow changed +148.3% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$3.0M→$1.4M3 prior comparisons
Current liabilities increased 20.3%
Current liabilities changed +20.3% from the comparable as-filed period.
$58.7M→$70.6M3 prior comparisons
R&D / revenue moved 4522 bp higher
R&D / revenue changed +4522 basis points from the comparable as-filed period.
32.63%→77.85%3 prior comparisons
Working capital / assets moved 3621 bp lower
Working capital / assets changed -3621 basis points from the comparable as-filed period.
-28.41%→-64.62%3 prior comparisons
Current ratio decreased 76.3%
Current ratio changed -76.3% from the comparable as-filed period.
0.38→0.093 prior comparisons
Operating cash-flow margin moved 6382 bp higher
Operating cash-flow margin changed +6382 basis points from the comparable as-filed period.
-26.19%→37.62%3 prior comparisons
Operating income increased 3.4%
Operating income changed +3.4% from the comparable as-filed period.
-$10.5M→-$10.1M3 prior comparisons
SBC / revenue moved 1983 bp lower
SBC / revenue changed -1983 basis points from the comparable as-filed period.
28.74%→8.91%1 prior comparisons
Current assets decreased 26.9%
Current assets changed -26.9% from the comparable as-filed period.
$14.5M→$10.6M2 prior comparisons
Operating income decreased 11.9%
Operating income changed -11.9% from the comparable as-filed period.
-$11.5M→-$12.9M1 prior comparisons
Operating cash flow changed across a low base
Operating cash flow changed -2788.2% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
-$144,000→-$4.2M1 prior comparisons
Inventory / revenue moved 587 bp higher
Inventory / revenue changed +587 basis points from the comparable as-filed period.
42.63%→48.50%1 prior comparisons
Selling, general & administrative decreased 26.4%
Selling, general & administrative changed -26.4% from the comparable as-filed period.
$12.7M→$9.3M1 prior comparisons
Shares outstanding increased 26.0%
Shares outstanding changed +26.0% from the comparable as-filed period.
22,484,239→28,328,8801 prior comparisons
Research & development increased 17.4%
Research & development changed +17.4% from the comparable as-filed period.
$3.9M→$4.6M1 prior comparisons
R&D / revenue moved 4490 bp higher
R&D / revenue changed +4490 basis points from the comparable as-filed period.
42.11%→87.02%1 prior comparisons
Operating cash-flow margin moved 7716 bp lower
Operating cash-flow margin changed -7716 basis points from the comparable as-filed period.
-1.55%→-78.71%1 prior comparisons
Total assets decreased 11.3%
Total assets changed -11.3% from the comparable as-filed period.
$128.8M→$114.2M2 prior comparisons
Current liabilities decreased 14.3%
Current liabilities changed -14.3% from the comparable as-filed period.
$76.2M→$65.3M2 prior comparisons
Working capital increased 11.3%
Working capital changed +11.3% from the comparable as-filed period.
-$61.7M→-$54.7M2 prior comparisons
Cash & equivalents decreased 9.8%
Cash & equivalents changed -9.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$133,000→$120,0002 prior comparisons
Current ratio decreased 14.8%
Current ratio changed -14.8% from the comparable as-filed period.
0.19→0.162 prior comparisons
Working capital / assets moved 3 bp lower
Working capital / assets changed -3 basis points from the comparable as-filed period.
-47.86%→-47.90%2 prior comparisons
Cost of revenue increased 0.5%
Cost of revenue changed +0.5% from the comparable as-filed period.
$3.9M→$3.9M0 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.